NasdaqCM - Delayed Quote USD

Cryoport, Inc. (CYRX)

16.03 -0.20 (-1.23%)
At close: April 25 at 4:00 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 9998
Avg. Estimate -0.35-0.33-1.3-1
Low Estimate -0.42-0.41-1.62-1.4
High Estimate -0.19-0.15-0.58-0.3
Year Ago EPS -0.16-0.42-2.21-1.3

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 8898
Avg. Estimate 58.76M60.29M245.68M272.21M
Low Estimate 56.6M57.4M242.6M263.93M
High Estimate 61.09M61.98M248.36M283.37M
Year Ago Sales 62.82M59.36M233.25M245.68M
Sales Growth (year/est) -6.50%1.60%5.30%10.80%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. -0.19-0.24-0.3-0.29
EPS Actual -0.16-0.42-0.31-1.31
Difference 0.03-0.18-0.01-1.02
Surprise % 15.80%-75.00%-3.30%-351.70%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate -0.35-0.33-1.3-1
7 Days Ago -0.35-0.33-1.3-1
30 Days Ago -0.35-0.33-1.3-0.95
60 Days Ago -0.26-0.25-0.96-0.68
90 Days Ago -0.27-0.26-0.98-0.68

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days 1------
Up Last 30 Days 1----1
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD CYRXIndustrySectorS&P 500
Current Qtr. -118.70%----1.50%
Next Qtr. 21.40%----12.10%
Current Year 41.20%----4.40%
Next Year 23.10%----13.20%
Next 5 Years (per annum) ------10.97%
Past 5 Years (per annum) --------

Research Analysis

Analyst Price Targets

15.00
18.33 Average
16.03 Current
22.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains UBS: Neutral to Neutral 3/15/2024
Reiterates Stephens & Co.: Equal-Weight to Equal-Weight 3/13/2024
Maintains Needham: Buy to Buy 3/13/2024
Maintains Needham: Buy to Buy 1/18/2024
Initiated Morgan Stanley: Equal-Weight 8/17/2023
Maintains Needham: Buy to Buy 8/10/2023